Seven Eight Capital, LP Nuvasive Inc Transaction History

Seven Eight Capital, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$36.81 - $48.12 $1.33 Million - $1.73 Million	36,046 New	36,046 $1.49 Million
Q1 2020 May 14, 2020	SELL	$32.82 - $81.13 $158,389 - $391,533	-4,826 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$60.96 - $77.7 $152,400 - $194,250	-2,500 Reduced 34.13%	4,826 $373,000
Q3 2019 Nov 14, 2019	BUY	$55.78 - $68.08 $408,644 - $498,754	7,326 New	7,326 $464,000
Q1 2018 May 14, 2018	SELL	$46.03 - $61.28 $2.32 Million - $3.09 Million	-50,483 Closed	0 $0

Q4 2017 Feb 12, 2018	BUY	$50.58 - $60.79 $1.28 Million - $1.54 Million	25,400 Added 101.26%	50,483 $2.95 Million
Q3 2017 Oct 16, 2017	BUY	$53.54 - $68.0 $1.34 Million - $1.71 Million	25,083	25,083 $1.39 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.